MindMed Provides Corporate Update and 2023 Outlook : vimarsa

/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing...

Related Keywords

Canada , Switzerland , San Francisco , California , United States , Canadian , Rob Barrow , Exchange Commission , Company Annual Report On Form , Development Program Updates , Prnewswire Mind Medicine Mindmed Inc , University Hospital Basel , Company Or Mindmed , Nasdaq , Chief Executive , Program Updates , Anticipated Milestones , Annual Report , Quarterly Report , Note Regarding Forward Looking Statements , Financial Condition , Mind Medicine Mindmed Inc ,